SYN - Synthetic Biologics reports Q2 results August, 08 2019 04:23 PM Synthetic Biologics Inc. Synthetic Biologics (NYSEMKT:SYN): Q2 GAAP EPS of -$0.23.Cash and cash equivalents of $21.7MShares +3%Press ReleaseMore news on: Synthetic Biologics, Inc., Earnings news and commentary, Stocks on the move, Healthcare stocks news, ,